PCN247 PROGRESSION-FREE SURVIVAL (PFS) WITH DARATUMUMAB- BORTEZOMIB-MELPHALAN-PREDNISONE (D-VMP) COMBINATION THERAPY AND ALTERNATIVE TREATMENTS FOR PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA (MM) INELIGIBLE FOR STEM CELL TRANSPLANTATION ...
May 1, 2019, 00:00
10.1016/j.jval.2019.04.368
https://www.valueinhealthjournal.com/article/S1098-3015(19)30560-1/fulltext
Title :
PCN247 PROGRESSION-FREE SURVIVAL (PFS) WITH DARATUMUMAB- BORTEZOMIB-MELPHALAN-PREDNISONE (D-VMP) COMBINATION THERAPY AND ALTERNATIVE TREATMENTS FOR PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA (MM) INELIGIBLE FOR STEM CELL TRANSPLANTATION ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30560-1&doi=10.1016/j.jval.2019.04.368
First page :
Section Title :
Open access? :
No
Section Order :
10017